NSC |
Compound |
Enrichment |
Correlation |
NSC 756134 |
GSK1023156A |
0.0382675857669588 |
0.27223506 |
NSC 756170 |
GSK317315A |
0.0382675857669588 |
0.43560653 |
NSC 757946 |
(1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one |
0.0382675857669588 |
-0.27956642 |
NSC 683326 |
Null |
0.0388857481216103 |
0.48905953 |
NSC 691424 |
Null |
0.0388857481216103 |
-0.024609754 |
NSC 700893 |
5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) |
0.0388857481216103 |
-0.19483843 |
NSC 756078 |
1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole |
0.0388857481216103 |
0.2100462 |
NSC 115928 |
Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) |
0.0420893367628876 |
0.72542081 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0420893367628876 |
0.65388785 |
NSC 292147 |
12-Hydroxyindolo[2,1-b]quinazoline-6(12H)-one |
0.0420893367628876 |
0.034856422 |